Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jens Van Loon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 2 Meeting abstract (Journal)
-
A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors
Vounckx, M., Tijtgat, J., Dirven, I., Vandenbroucke, F., Raeymaeckers, S., Ilsen, B., Ben Mustapha, S., Van Loon, J., Stevens, L., Geeraerts, X., Van Riet, I., Dufait, I., Tuyaerts, S., Decoster, L., De Ridder, M. & Neyns, B., 2 Nov 2023, In: Journal for immunotherapy of cancer. 11, 1, 1 p., 694.Research output: Contribution to journal › Meeting abstract (Journal)
Open AccessFile8 Downloads (Pure) -
Total neoadjuvant treatment of rectal cancer by MRI-guided radiotherapy
De Ridder, M., Bezuidenhout, J. B., Van Loon, J., Platteaux, N., Everaert, T., Bom, A-S., Van Eetvelde, E., Kortbeek, K., Sermeus, A., De Haar-Holleman, A., Van Laere, S., Dufait, I. & Gevaert, T., 2023, In: Annals of Oncology. 34, 1, p. 145 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access